Abstract
BackgroundThe limited number of systematic, controlled studies that assess the safety and efficacy of psychotropic medications for children reinforce the hesitation and reluctance of parents to administer such medications. The aim of this study was to investigate the attitudes of parents of children with psychiatric disorders, towards psychotropic medication.MethodsA 20-item questionnaire was distributed to 140 parents during their first contact with an outpatient child psychiatric service. The questionnaire comprised of questions regarding the opinions, knowledge and attitudes of parents towards children's psychotropic medication. Sociodemographic data concerning parents and children were also recorded. Frequency tables were created and the chi-square test and Fisher's exact tests were used for the comparison of the participants' responses according to sex, educational level, age and gender of the child and use of medication.ResultsRespondents were mostly mothers aged 25–45 years. Children for whom they asked for help with were mostly boys, aged between 6 and 12 years old. A total of 83% of the subjects stated that they knew psychotropic drugs are classified into categories, each having a distinct mechanism of action and effectiveness. A total of 40% believe that there is a proper use of psychotropic medication, while 20% believe that psychiatrists unnecessarily use high doses of psychotropic medication. A total of 80% fear psychotropic agents more than other types of medication. Most parents are afraid to administer psychotropic medication to their child when compared to any other medication, and believe that psychotherapy is the most effective method of dealing with every kind of mental disorders, including childhood schizophrenia (65%). The belief that children who take psychotropic medication from early childhood are more likely to develop drug addiction later is correlated with the parental level of education.ConclusionParents' opinions and beliefs are not in line with scientific facts. This suggests a need to further inform the parents on the safety and efficacy of psychotropic medication in order to improve treatment compliance.
Highlights
The limited number of systematic, controlled studies that assess the safety and efficacy of psychotropic medications for children reinforce the hesitation and reluctance of parents to administer such medications
Psychotropic medications have been used for the treatment of psychiatric disorders for more than 50 years, less attention has been given to their utilization for the treatment of psychiatric disorders in children and adolescents
In some countries, including our own [5], the lack of research on the efficacy of psychotropic medication on mental disorders of childhood contributes to the child psychiatrist's hesitation to suggest drug treatment
Summary
The limited number of systematic, controlled studies that assess the safety and efficacy of psychotropic medications for children reinforce the hesitation and reluctance of parents to administer such medications. Clinical trials in children raise methodological problems, such as the forming of homogeneous groups due to the difficulty in defining diagnostic criteria and the measurement of the changes that the treatment has caused [3] They raise clinical, moral and legal dilemmas – and as a consequence controlled, double-blind studies and obliging child psychiatrists to draw information from them concerning the efficacy and safety of medication from open studies remain few and far between in child psychiatry[4]. Child psychiatrists are affected by the existing negative attitudes of the public, and their hesitation, in turn, affects the acceptance of drug treatment by the parents
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
